166 related articles for article (PubMed ID: 9211773)
21. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results.
Lee IH; Kim KH; Jeon P; Byun HS; Kim HJ; Kim ST; Kim YW; Kim DI; Choi JY
Korean J Radiol; 2009; 10(3):269-76. PubMed ID: 19412515
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
Spence J; Krings T; TerBrugge KG; Agid R
Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
[TBL] [Abstract][Full Text] [Related]
23. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
[TBL] [Abstract][Full Text] [Related]
24. Patient satisfaction after sclerotherapy of venous malformations in children.
Nakahata K; Uehara S; Zenitani M; Nakamura M; Osuga K; Okuyama H
Pediatr Int; 2016 Aug; 58(8):721-5. PubMed ID: 26662951
[TBL] [Abstract][Full Text] [Related]
25. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
Andreisek G; Nanz D; Weishaupt D; Pfammatter T
J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
[TBL] [Abstract][Full Text] [Related]
26. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
27. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification.
Goyal M; Causer PA; Armstrong D
Radiology; 2002 Jun; 223(3):639-44. PubMed ID: 12034929
[TBL] [Abstract][Full Text] [Related]
28. Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol.
Weitz-Tuoretmaa A; Keski-Nisula L; Rautio R; Laranne J
Acta Radiol; 2018 Aug; 59(8):946-952. PubMed ID: 29124942
[TBL] [Abstract][Full Text] [Related]
29. Treatment of venous malformations--comparison to lymphatic malformations.
Schumacher M; Ernemann U; Berlis A; Weber J
Lymphology; 2008 Sep; 41(3):139-46. PubMed ID: 19013882
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and treatment of intermuscular venous malformations: A retrospective study in one center.
Xu M; Wang M; Cheng Y; Ni X; Xu Y; Wang Q; Yuan S
Phlebology; 2020 Jul; 35(6):384-393. PubMed ID: 31663826
[TBL] [Abstract][Full Text] [Related]
31. Venous Malformations Sclerotherapy: Outcomes, Patient Satisfaction and Predictors of Treatment Success.
Khaitovich B; Kalderon E; Komisar O; Eifer M; Raskin D; Rimon U
Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1695-1701. PubMed ID: 31538233
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):695-8. PubMed ID: 24235099
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.
Hu X; Chen D; Jiang C; Jin Y; Chen H; Ma G; Lin X
Head Neck; 2011 Nov; 33(11):1616-21. PubMed ID: 21990226
[TBL] [Abstract][Full Text] [Related]
34. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations.
Li L; Zeng XQ; Li YH
AJR Am J Roentgenol; 2010 May; 194(5):W439-44. PubMed ID: 20410391
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy.
Mimura H; Kanazawa S; Yasui K; Fujiwara H; Hyodo T; Mukai T; Dendo S; Iguchi T; Hiraki T; Koshima I; Hiraki Y
Acta Med Okayama; 2003 Oct; 57(5):227-34. PubMed ID: 14679400
[TBL] [Abstract][Full Text] [Related]
36. Primum non nocere: Is it always true? The use of absolute ethanol in the management of congenital vascular malformations.
Villavicencio JL
J Vasc Surg; 2001 Apr; 33(4):904-6. PubMed ID: 11296353
[No Abstract] [Full Text] [Related]
37. Digital subtraction angiography (DSA) guided sequential sclerotherapy for maxillofacial vein malformation.
Meng J; Zhuang QW; Gu QP; Zhang J; Li ZP; Si YM
Eur Rev Med Pharmacol Sci; 2014; 18(12):1709-12. PubMed ID: 24992611
[TBL] [Abstract][Full Text] [Related]
38. [Combined surgery and sclerotherapy for massive venous malformations of the tongue].
Huang X; Zou H; Guo X; Zhao Y
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jan; 32(1):14-7. PubMed ID: 27197473
[TBL] [Abstract][Full Text] [Related]
39. Current concepts in diagnosis and treatment of venous malformations.
Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
[TBL] [Abstract][Full Text] [Related]
40. Peripheral venous malformations with a dominant outflow vein: results of ethanol embolization.
Rokni-Yazdi H; Ghajarzadeh M; Keyvan AH; Namavar MJ; Azizi S
Acta Med Iran; 2014; 52(11):868-71. PubMed ID: 25415823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
